The outlook of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial surge generated substantial gains, generic alternatives have significantly eroded sales . https://bookmarkingdepot.com/story21556922/the-copyright-and-pharma-a-speculative-opportunity